Biogen Balance Sheet Health
Financial Health criteria checks 6/6
Biogen has a total shareholder equity of $16.4B and total debt of $6.3B, which brings its debt-to-equity ratio to 38.5%. Its total assets and total liabilities are $28.3B and $12.0B respectively. Biogen's EBIT is $2.3B making its interest coverage ratio 11.9. It has cash and short-term investments of $1.7B.
Key information
38.5%
Debt to equity ratio
US$6.29b
Debt
| Interest coverage ratio | 11.9x |
| Cash | US$1.70b |
| Equity | US$16.36b |
| Total liabilities | US$11.95b |
| Total assets | US$28.31b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BIIB *'s short term assets ($6.8B) exceed its short term liabilities ($5.4B).
Long Term Liabilities: BIIB *'s short term assets ($6.8B) exceed its long term liabilities ($6.5B).
Debt to Equity History and Analysis
Debt Level: BIIB *'s net debt to equity ratio (28.1%) is considered satisfactory.
Reducing Debt: BIIB *'s debt to equity ratio has reduced from 42.5% to 38.5% over the past 5 years.
Debt Coverage: BIIB *'s debt is well covered by operating cash flow (33.8%).
Interest Coverage: BIIB *'s interest payments on its debt are well covered by EBIT (11.9x coverage).